ABBV.USD
AbbVie, Inc. · SIX:ABBV.USD
288.10 USD0.1500 +0.05%
AbbVie, Inc. (SIX:ABBV.USD) last traded at 288.10 USD, up 0.05% on the day. Over the past year the stock is up 0.05%. Its 52-week range is 288.10 to 288.10. It is in the Health Technology sector (Pharmaceuticals: Major).
Key statistics
Open288.10
Day range288.10 – 288.10
52-week range288.10 – 288.10
Volume65
Market cap521.11 B
P/E49.52
EPS (TTM)5.82
Dividend yield2.32%
Beta (1 year)0.6762
Revenue (TTM)66.01 B
Employees57.00 K
Performance
+0.05%1 month
+0.05%3 months
+0.05%6 months
+0.05%Year to date
+0.05%1 year
Latest headlines
- Canaccord Genuity maintains AbbVie at Buy, raises price target to $338 from $290TradingView · 02 Nov 2026
- AbbVie Is Maintained at Overweight by Cantor FitzgeraldDow Jones Newswires · 02 Nov 2026
- Cantor Fitzgerald maintains AbbVie at Overweight, raises price target to $325 from $290TradingView · 02 Nov 2026
- Weekly Recap: Q3 financial gains and Skyrizi Crohn’s FDA approvalTradingView · 02 Nov 2026
- The top 5 analyst questions from AbbVie’s Q3 earnings callStock Story · 01 Nov 2026
- Healthcare Earnings Scoreboard: 96% beat EPS estimates, 70% post Y/Y earnings growthSeeking Alpha · 31 Oct 2026
- Key facts: AbbVie, Inc. Q3 revenue $17.404B; Skyrizi approved; lutikizumab successTradingView · 31 Oct 2026
- ABBV Q3 deep dive: Immunology and neuroscience drive growth, pipeline progress continuesStock Story · 31 Oct 2026
Market data from TradingView’s public feed, delayed as the exchange requires. SuperCharting is charting software and gives no investment advice.